Abstract
MA16.05 Phase Ib Trial of Neoadjuvant Low Dose Radiotherapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jtho.2023.09.231
Copy DOIJournal: Journal of Thoracic Oncology | Publication Date: Oct 31, 2023 |
MA16.05 Phase Ib Trial of Neoadjuvant Low Dose Radiotherapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC
Join us for a 30 min session where you can share your feedback and ask us any queries you have